Skip to Content
Merck

Serum protein binding of desmethyl-methsuximide.

Clinical neuropharmacology (1999-08-12)
N Wad, B Bourgeois, G Krämer
PMID10442255
ABSTRACT

Serum protein binding of desmethyl-methsuximide (DM-MSM) in serum from 23 patients on polytherapy were determined using ultrafiltration and high-performance liquid chromatography. Desmethyl-methsuximide, The active metabolite of methsuximide (MSM), was found to have a moderate protein binding ranging between 45% and 60%.

MATERIALS
Product Number
Brand
Product Description
860581
Sigma-Aldrich
α-Methyl-α-phenylsuccinimide, 99%